Meeting Contemporary Challenges: Development of Nanomaterials for Veterinary Medicine

In recent decades, nanotechnology has been rapidly advancing in various fields of human activity, including veterinary medicine. The review presents up-to-date information on recent advancements in nanotechnology in the field and an overview of the types of nanoparticles used in veterinary medicine...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutics 2023-09, Vol.15 (9), p.2326
Main Authors: Danchuk, Oleksii, Levchenko, Anna, da Silva Mesquita, Rochelly, Danchuk, Vyacheslav, Cengiz, Seyda, Cengiz, Mehmet, Grafov, Andriy
Format: Article
Language:English
Subjects:
animal disease
Animal diseases
Biocompatibility
Cadmium telluride
Citation management software
Composite materials
diagnostics
Drug resistance in microorganisms
Drugs
Gene therapy
Genetic vectors
Infectious diseases
Influenza
Nanomaterials
Nanoparticles
Nanotechnology
Pathogens
Prevention
Quality control
Quantum dots
Review
Streptococcus infections
Toxicity
treatment
Vaccines
Veterinary medicine
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In recent decades, nanotechnology has been rapidly advancing in various fields of human activity, including veterinary medicine. The review presents up-to-date information on recent advancements in nanotechnology in the field and an overview of the types of nanoparticles used in veterinary medicine and animal husbandry, their characteristics, and their areas of application. Currently, a wide range of nanomaterials has been implemented into veterinary practice, including pharmaceuticals, diagnostic devices, feed additives, and vaccines. The application of nanoformulations gave rise to innovative strategies in the treatment of animal diseases. For example, antibiotics delivered on nanoplatforms demonstrated higher efficacy and lower toxicity and dosage requirements when compared to conventional pharmaceuticals, providing a possibility to solve antibiotic resistance issues. Nanoparticle-based drugs showed promising results in the treatment of animal parasitoses and neoplastic diseases. However, the latter area is currently more developed in human medicine. Owing to the size compatibility, nanomaterials have been applied as gene delivery vectors in veterinary gene therapy. Veterinary medicine is at the forefront of the development of innovative nanovaccines inducing both humoral and cellular immune responses. The paper provides a brief overview of current topics in nanomaterial safety, potential risks associated with the use of nanomaterials, and relevant regulatory aspects.
ISSN:1999-4923
1999-4923
DOI:10.3390/pharmaceutics15092326